The use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic AB peptides in amyloidopathies

Details for Australian Patent Application No. 2004316119 (hide)

Owner Merz Pharma GmbH & Co. KgaA

Inventors Banarjee, Pradeep; Gupta, Sandeep; Lahiri, Debomoy K.; Farlow, Martin R.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004316119

PCT Pub. Number WO2005/079779

Priority 60/513,700 22.10.03 US

Filing date 22 October 2004

Wipo publication date 1 September 2005

Acceptance publication date 24 April 2008

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/079779 Priority application(s): WO2005/079779

24 April 2008 Application Accepted

  Published as AU-B-2004316119

28 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004316121-Planar guides to visually aid orthodontic appliance placement within a threedimensional (3D) environment

2004316118-Nanopowder synthesis using pulsed arc discharge and applied magnetic field